4baseCare, a Bengaluru-based healthcare startup focused on precision oncology, has raised $6 million in a Series A round funds round led by Capital of Yaliwith the participation of others investors.
The startup will use the capital raised to enhance its product offering and scale up its operations for further expansion across India as well as other countries in Asia and the Middle East.
“This funding will enable us to further enhance our product offering and advance our mission of making personalized cancer care accessible to millions of people,” said Hitesh Goswami, CEO and co-founder of 4baseCare.
Who are the founders?
Founded in 2018 by Hitesh Goswami and Kshitij Rishi, 4baseCare specializes in precision oncology through advanced genomics and digital health technologies.
The startup says its genomic testing has had a substantial impact in Southeast Asia, benefiting more than 10,000 cancer patients.
Its genomics-based tests include Indiegene, which the company claims is the first Indian population-specific cancer gene panel for biomarker testing.
Creation of new genomics laboratories
The funding would also help 4baseCare expand its reach by establishing new genomics labs in the Philippines, Nepal and Dubai in the coming months.
These efforts are part of the company’s broader strategy to improve clinical insights and provide data-driven treatment recommendations.
“4baseCare was founded with the aim of addressing the critical genomic data gap in cancer care. Our journey from developing TARGT Indiegene to impacting the lives of over 10,000 patients has been a highly rewarding experience. The success of our trial and our growth over the years is a result of the exceptional support of our investors and the valuable insights of our advisory board,” said Goswami.
Investor comments
Mathew Cyriac, Founding General Partner at Yali Capital, said: “The genomics landscape in cancer care offers a tremendous opportunity to build high-impact companies while improving millions of lives. As a technology-focused fund, we are particularly excited about 4baseCare’s ability to improve genomic testing with data from underrepresented populations, leading to better treatment recommendations. 4baseCare has demonstrated impressive growth over the past few years and we look forward to helping the team build a sustainable and profitable business.”
4baseCare recently added Francis de Souza, former CEO of Illumina and Silicon Valley veteran, to its advisory board.
DeSouza brings more than 30 years of experience in genomics, technology and healthcare, providing invaluable insights that will guide 4baseCare’s future developments.
Disclaimer:
The information contained in this post is for general information purposes only. We make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the post for any purpose.
We respect the intellectual property rights of content creators. If you are the owner of any material featured on our website and have concerns about its use, please contact us. We are committed to addressing any copyright issues promptly and will remove any material within 2 days of receiving a request from the rightful owner.